The use of dextromethorphan (DXM) in medicine has been around for decades. It is a common ingredient in many over-the-counter (OTC) cough medicines, and is also used to treat certain types of pain. Recently, however, there has been a rise in the use of high-dose DXM for recreational purposes. This has led to an increase in potential health risks, particularly among adolescents and young adults. In this article, we will explore the effects of high-dose DXM and discuss why it is important for doctors to be aware of the potential risks associated with its use.
Dextromethorphan (DXM) is an opioid derivative that is commonly found in OTC cough and cold medicines. It works by blocking the cough reflex, which helps to suppress coughing. DXM is also used to treat certain types of pain, such as neuropathic pain. It is available in both tablet and liquid forms, and is typically taken in doses of 10-30 milligrams (mg) per day.
High-dose DXM is defined as taking more than 30 mg of DXM in a single dose, or taking multiple doses of DXM throughout the day. This type of DXM use is also known as “stacking”, and it is becoming increasingly popular among adolescents and young adults. High-dose DXM is often taken to achieve a “high”, or to experience a sense of euphoria.
There are a number of potential health risks associated with high-dose DXM use. These include an increased risk of liver damage, increased heart rate and blood pressure, and increased risk of seizures. Additionally, high-dose DXM can lead to an increased risk of addiction and dependence.
High-dose DXM use has also been associated with a number of neuropsychiatric effects, such as confusion, disorientation, and hallucinations. These effects can be particularly dangerous, as they can lead to impaired decision-making and an increased risk of self-harm or injury.
High-dose DXM use can also lead to long-term effects, such as memory loss, cognitive impairment, and depression. Additionally, it has been linked to an increased risk of developing certain types of cancers, such as liver and kidney cancer.
Given the potential health risks associated with high-dose DXM use, it is important for doctors to be aware of the dangers associated with this type of drug use. Doctors should be aware of the signs and symptoms of DXM use, and should be prepared to provide appropriate treatment and support to those who are struggling with addiction. Additionally, doctors should be aware of the potential long-term effects of high-dose DXM use, and should be prepared to provide appropriate follow-up care and monitoring.
High-dose DXM use is becoming increasingly popular among adolescents and young adults, and it is associated with a number of potential health risks. It is important for doctors to be aware of the potential dangers associated with this type of drug use, and to be prepared to provide appropriate treatment and support to those who are struggling with addiction. By understanding the effects of high-dose DXM, doctors can help to ensure that their patients are safe and healthy.
1.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
4.
A prostate cancer risk prediction algorithm could help target men at highest risk
5.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Bone Marrow Regeneration in Hematologic Recovery
3.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
4.
Iron Homeostasis Throughout the Female Lifespan
5.
Demystifying Lymphocytes: Everything You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation